Ronnda L. Bartel

StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.

MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA.

SRS Capital LLC offers investment banking and financial services. It provides advisory services which includes mergers & acquisitions, divestitures, strategic business alliances and direct investing. The company also provides services to the pharmaceutical, healthcare, medical technology and biotechnology fields. SRS Capital was founded by Stanley B. Stein and is headquartered in New York, NY.